Literature DB >> 12571372

Alterations in tumour suppressor gene p53 in human gliomas from Indian patients.

Poornima Phatak1, S Kalai Selvi, T Divya, A S Hegde, Sridevi Hegde, Kumaravel Somasundaram.   

Abstract

Alterations in tumour suppressor p53 gene are the most common defects seen in a variety of human cancers. In order to study the significance of the p53 gene in the genesis and development of human glioma from Indian patients, we checked 44 untreated primary gliomas for mutations in exons 5-9 of the p53 gene by PCR-SSCP and DNA sequencing. Sequencing analysis revealed six missense mutations. The incidence of p53 mutations was 13.6% (6 of 44). All the six mutations were found to be located in the central core domain of p53, which carries the sequence-specific DNA-binding domain. These results suggest a rather low incidence but a definite involvement of p53 mutations in the gliomas of Indian patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12571372     DOI: 10.1007/BF02708375

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  30 in total

Review 1.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

2.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

3.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

Review 4.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

5.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

6.  Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme.

Authors:  M Fujimoto; D W Fults; G A Thomas; Y Nakamura; M P Heilbrun; R White; J L Story; S L Naylor; K S Kagan-Hallet; P J Sheridan
Journal:  Genomics       Date:  1989-02       Impact factor: 5.736

7.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

8.  Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.

Authors:  S Mashiyama; Y Murakami; T Yoshimoto; T Sekiya; K Hayashi
Journal:  Oncogene       Date:  1991-08       Impact factor: 9.867

Review 9.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

10.  p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.

Authors:  D Fults; D Brockmeyer; M W Tullous; C A Pedone; R M Cawthon
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

View more
  7 in total

1.  TP53 codon 72 polymorphism and glioma risk: A meta-analysis.

Authors:  Minghan Shi; Ruishan Huang; Chunying Pei; Xiuzhi Jia; Chuanlu Jiang; Huan Ren
Journal:  Oncol Lett       Date:  2011-12-12       Impact factor: 2.967

2.  CD133 and BMI1 expressions and its prognostic role in primary glioblastoma.

Authors:  M K Sibin; C H Lavanya; Dhananjaya I Bhat; Narasinga Rao; N Geethashree; W Vibhuti; G K Chetan
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

Review 3.  Mutations of the human interferon alpha-2b gene in brain tumor patients exposed to different environmental conditions.

Authors:  S Shahid; M Nawaz Chaudhry; N Mahmood; S Sheikh
Journal:  Cancer Gene Ther       Date:  2015-04-03       Impact factor: 5.987

4.  Association of matrix metalloproteinase-1 gene polymorphism with glioblastoma multiforme in a northern Indian population.

Authors:  Nitin Malik; Raj Kumar; Kashi N Prasad; Priyanka Kawal; Arun Srivastava; Ashok K Mahapatra
Journal:  J Neurooncol       Date:  2010-08-14       Impact factor: 4.130

5.  Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population.

Authors:  Mahalakshmi Palani; Sabarinathan Devan; R Arunkumar; A J Vanisree
Journal:  Med Oncol       Date:  2010-09-16       Impact factor: 3.064

6.  Significance of p53 and CD31 in astrogliomas.

Authors:  Abdul-Zaher M Khattab; Magdy I Ahmed; Mohamed A Fouad; Waleed A Essa
Journal:  Med Oncol       Date:  2008-09-20       Impact factor: 3.064

7.  Biochemical and cytogenetic analysis of brain tissues in different grades of glioma patients.

Authors:  Mahalakshmi Palani; R Arunkumar; Vanisree Arambakkam Janardhanam
Journal:  Ann Neurosci       Date:  2010-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.